The global market for Brain Tumor Diagnostics and Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnostics and Therapeutics.

The Brain Tumor Diagnostics and Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brain Tumor Diagnostics and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brain Tumor Diagnostics and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Brain Tumor Diagnostics and Therapeutics Market Report

Report Metric	Details
Report Name	Brain Tumor Diagnostics and Therapeutics Market
CAGR	5%
Segment by Type	Surgery Radiation Therapy Targeted Therapy Chemotherapy Others
Segment by Application	Hospitals and Cancer Center Oncology Treatment Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Roche, Merck, Curtana Pharmaceuticals, GE Healthcare, Hitachi Medical, Philips Healthcare, Novocure, AbbVie, Daiichi Sankyo, Genetech, Carthera, EMulate Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Tumor Diagnostics and Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Brain Tumor Diagnostics and Therapeutics Market report?

Ans: The main players in the Brain Tumor Diagnostics and Therapeutics Market are Pfizer, Novartis, Roche, Merck, Curtana Pharmaceuticals, GE Healthcare, Hitachi Medical, Philips Healthcare, Novocure, AbbVie, Daiichi Sankyo, Genetech, Carthera, EMulate Therapeutics

What are the Application segmentation covered in the Brain Tumor Diagnostics and Therapeutics Market report?

Ans: The Applications covered in the Brain Tumor Diagnostics and Therapeutics Market report are Hospitals and Cancer Center, Oncology Treatment Centers, Others

What are the Type segmentation covered in the Brain Tumor Diagnostics and Therapeutics Market report?

Ans: The Types covered in the Brain Tumor Diagnostics and Therapeutics Market report are Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Surgery

1.2.3 Radiation Therapy

1.2.4 Targeted Therapy

1.2.5 Chemotherapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Brain Tumor Diagnostics and Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Cancer Center

1.3.3 Oncology Treatment Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Brain Tumor Diagnostics and Therapeutics Market Perspective (2020-2031)

2.2 Global Brain Tumor Diagnostics and Therapeutics Growth Trends by Region

2.2.1 Global Brain Tumor Diagnostics and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Brain Tumor Diagnostics and Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Brain Tumor Diagnostics and Therapeutics Market Dynamics

2.3.1 Brain Tumor Diagnostics and Therapeutics Industry Trends

2.3.2 Brain Tumor Diagnostics and Therapeutics Market Drivers

2.3.3 Brain Tumor Diagnostics and Therapeutics Market Challenges

2.3.4 Brain Tumor Diagnostics and Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Brain Tumor Diagnostics and Therapeutics Players by Revenue

3.1.1 Global Top Brain Tumor Diagnostics and Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Brain Tumor Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Brain Tumor Diagnostics and Therapeutics Revenue

3.4 Global Brain Tumor Diagnostics and Therapeutics Market Concentration Ratio

3.4.1 Global Brain Tumor Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnostics and Therapeutics Revenue in 2024

3.5 Global Key Players of Brain Tumor Diagnostics and Therapeutics Head office and Area Served

3.6 Global Key Players of Brain Tumor Diagnostics and Therapeutics, Product and Application

3.7 Global Key Players of Brain Tumor Diagnostics and Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Tumor Diagnostics and Therapeutics Breakdown Data by Type

4.1 Global Brain Tumor Diagnostics and Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Type (2026-2031)

5 Brain Tumor Diagnostics and Therapeutics Breakdown Data by Application

5.1 Global Brain Tumor Diagnostics and Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Brain Tumor Diagnostics and Therapeutics Market Size (2020-2031)

6.2 North America Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025)

6.4 North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Brain Tumor Diagnostics and Therapeutics Market Size (2020-2031)

7.2 Europe Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025)

7.4 Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Brain Tumor Diagnostics and Therapeutics Market Size (2020-2031)

9.2 Latin America Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Brain Tumor Diagnostics and Therapeutics Introduction

11.1.4 Pfizer Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Brain Tumor Diagnostics and Therapeutics Introduction

11.2.4 Novartis Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Brain Tumor Diagnostics and Therapeutics Introduction

11.3.4 Roche Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Brain Tumor Diagnostics and Therapeutics Introduction

11.4.4 Merck Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Curtana Pharmaceuticals

11.5.1 Curtana Pharmaceuticals Company Details

11.5.2 Curtana Pharmaceuticals Business Overview

11.5.3 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Introduction

11.5.4 Curtana Pharmaceuticals Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.5.5 Curtana Pharmaceuticals Recent Development

11.6 GE Healthcare

11.6.1 GE Healthcare Company Details

11.6.2 GE Healthcare Business Overview

11.6.3 GE Healthcare Brain Tumor Diagnostics and Therapeutics Introduction

11.6.4 GE Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.6.5 GE Healthcare Recent Development

11.7 Hitachi Medical

11.7.1 Hitachi Medical Company Details

11.7.2 Hitachi Medical Business Overview

11.7.3 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Introduction

11.7.4 Hitachi Medical Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.7.5 Hitachi Medical Recent Development

11.8 Philips Healthcare

11.8.1 Philips Healthcare Company Details

11.8.2 Philips Healthcare Business Overview

11.8.3 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Introduction

11.8.4 Philips Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.8.5 Philips Healthcare Recent Development

11.9 Novocure

11.9.1 Novocure Company Details

11.9.2 Novocure Business Overview

11.9.3 Novocure Brain Tumor Diagnostics and Therapeutics Introduction

11.9.4 Novocure Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.9.5 Novocure Recent Development

11.10 AbbVie

11.10.1 AbbVie Company Details

11.10.2 AbbVie Business Overview

11.10.3 AbbVie Brain Tumor Diagnostics and Therapeutics Introduction

11.10.4 AbbVie Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.10.5 AbbVie Recent Development

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Details

11.11.2 Daiichi Sankyo Business Overview

11.11.3 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Introduction

11.11.4 Daiichi Sankyo Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.11.5 Daiichi Sankyo Recent Development

11.12 Genetech

11.12.1 Genetech Company Details

11.12.2 Genetech Business Overview

11.12.3 Genetech Brain Tumor Diagnostics and Therapeutics Introduction

11.12.4 Genetech Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.12.5 Genetech Recent Development

11.13 Carthera

11.13.1 Carthera Company Details

11.13.2 Carthera Business Overview

11.13.3 Carthera Brain Tumor Diagnostics and Therapeutics Introduction

11.13.4 Carthera Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.13.5 Carthera Recent Development

11.14 EMulate Therapeutics

11.14.1 EMulate Therapeutics Company Details

11.14.2 EMulate Therapeutics Business Overview

11.14.3 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Introduction

11.14.4 EMulate Therapeutics Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

11.14.5 EMulate Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Curtana Pharmaceuticals

List of Tables

Table 1. Global Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Surgery

Table 3. Key Players of Radiation Therapy

Table 4. Key Players of Targeted Therapy

Table 5. Key Players of Chemotherapy

Table 6. Key Players of Others

Table 7. Global Brain Tumor Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Brain Tumor Diagnostics and Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Brain Tumor Diagnostics and Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Brain Tumor Diagnostics and Therapeutics Market Share by Region (2020-2025)

Table 11. Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Brain Tumor Diagnostics and Therapeutics Market Share by Region (2026-2031)

Table 13. Brain Tumor Diagnostics and Therapeutics Market Trends

Table 14. Brain Tumor Diagnostics and Therapeutics Market Drivers

Table 15. Brain Tumor Diagnostics and Therapeutics Market Challenges

Table 16. Brain Tumor Diagnostics and Therapeutics Market Restraints

Table 17. Global Brain Tumor Diagnostics and Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Brain Tumor Diagnostics and Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Brain Tumor Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnostics and Therapeutics as of 2024)

Table 20. Ranking of Global Top Brain Tumor Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Brain Tumor Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Brain Tumor Diagnostics and Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Brain Tumor Diagnostics and Therapeutics, Product and Application

Table 24. Global Key Players of Brain Tumor Diagnostics and Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Brain Tumor Diagnostics and Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Brain Tumor Diagnostics and Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer Company Details

Table 50. Pfizer Business Overview

Table 51. Pfizer Brain Tumor Diagnostics and Therapeutics Product

Table 52. Pfizer Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis Brain Tumor Diagnostics and Therapeutics Product

Table 57. Novartis Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Roche Company Details

Table 60. Roche Business Overview

Table 61. Roche Brain Tumor Diagnostics and Therapeutics Product

Table 62. Roche Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 63. Roche Recent Development

Table 64. Merck Company Details

Table 65. Merck Business Overview

Table 66. Merck Brain Tumor Diagnostics and Therapeutics Product

Table 67. Merck Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Merck Recent Development

Table 69. Curtana Pharmaceuticals Company Details

Table 70. Curtana Pharmaceuticals Business Overview

Table 71. Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Product

Table 72. Curtana Pharmaceuticals Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Curtana Pharmaceuticals Recent Development

Table 74. GE Healthcare Company Details

Table 75. GE Healthcare Business Overview

Table 76. GE Healthcare Brain Tumor Diagnostics and Therapeutics Product

Table 77. GE Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 78. GE Healthcare Recent Development

Table 79. Hitachi Medical Company Details

Table 80. Hitachi Medical Business Overview

Table 81. Hitachi Medical Brain Tumor Diagnostics and Therapeutics Product

Table 82. Hitachi Medical Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Hitachi Medical Recent Development

Table 84. Philips Healthcare Company Details

Table 85. Philips Healthcare Business Overview

Table 86. Philips Healthcare Brain Tumor Diagnostics and Therapeutics Product

Table 87. Philips Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 88. Philips Healthcare Recent Development

Table 89. Novocure Company Details

Table 90. Novocure Business Overview

Table 91. Novocure Brain Tumor Diagnostics and Therapeutics Product

Table 92. Novocure Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Novocure Recent Development

Table 94. AbbVie Company Details

Table 95. AbbVie Business Overview

Table 96. AbbVie Brain Tumor Diagnostics and Therapeutics Product

Table 97. AbbVie Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 98. AbbVie Recent Development

Table 99. Daiichi Sankyo Company Details

Table 100. Daiichi Sankyo Business Overview

Table 101. Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Product

Table 102. Daiichi Sankyo Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 103. Daiichi Sankyo Recent Development

Table 104. Genetech Company Details

Table 105. Genetech Business Overview

Table 106. Genetech Brain Tumor Diagnostics and Therapeutics Product

Table 107. Genetech Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 108. Genetech Recent Development

Table 109. Carthera Company Details

Table 110. Carthera Business Overview

Table 111. Carthera Brain Tumor Diagnostics and Therapeutics Product

Table 112. Carthera Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 113. Carthera Recent Development

Table 114. EMulate Therapeutics Company Details

Table 115. EMulate Therapeutics Business Overview

Table 116. EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Product

Table 117. EMulate Therapeutics Revenue in Brain Tumor Diagnostics and Therapeutics Business (2020-2025) & (US$ Million)

Table 118. EMulate Therapeutics Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

Table 122. Authors List of This Report

List of Figures

Figure 1. Brain Tumor Diagnostics and Therapeutics Picture

Figure 2. Global Brain Tumor Diagnostics and Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Brain Tumor Diagnostics and Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Surgery Features

Figure 5. Radiation Therapy Features

Figure 6. Targeted Therapy Features

Figure 7. Chemotherapy Features

Figure 8. Others Features

Figure 9. Global Brain Tumor Diagnostics and Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Brain Tumor Diagnostics and Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Hospitals and Cancer Center Case Studies

Figure 12. Oncology Treatment Centers Case Studies

Figure 13. Others Case Studies

Figure 14. Brain Tumor Diagnostics and Therapeutics Report Years Considered

Figure 15. Global Brain Tumor Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Brain Tumor Diagnostics and Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Brain Tumor Diagnostics and Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Brain Tumor Diagnostics and Therapeutics Market Share by Players in 2024

Figure 19. Global Top Brain Tumor Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnostics and Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Brain Tumor Diagnostics and Therapeutics Revenue in 2024

Figure 21. North America Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Brain Tumor Diagnostics and Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Brain Tumor Diagnostics and Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Share by Region (2020-2031)

Figure 35. China Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Brain Tumor Diagnostics and Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 54. Curtana Pharmaceuticals Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 55. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 56. Hitachi Medical Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 57. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 58. Novocure Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 59. AbbVie Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 60. Daiichi Sankyo Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 61. Genetech Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 62. Carthera Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 63. EMulate Therapeutics Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Brain Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Diagnostics Service Market Research Report 2025

Global Cancer Tissue Diagnostics Market Research Report 2024

Global Recurrent Glioblastoma Multiforme Treatment Market Research Report 2025

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Meningioma Drug Market Research Report 2024

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Global Lung Cancer Diagnostic Tests Market Research Report 2024

Global Cognitive Diagnostics Market Research Report 2024

Skin Cancer Diagnostics Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neuroendocrine Tumor Drug Market Research Report 2024

Solid Tumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intracranial Treatment Drug Market Research Report 2025

Global Oligodendroglioma Treatment Market Research Report 2024

Tumor Immunotherapy Market

Global Kidney Cancer Diagnosis Market Research Report 2025

Global Personalized Medicine for Cancer Market Research Report 2025

Global Cancer Diagnostic Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27M19164

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Cancer Early Screening NGS Testing Platform Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29B19202

Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Cancer Treatment Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I9425

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

Global Checkpoint Inhibitors for Treating Cancer Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-25J2388

Wed Jun 04 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »

Global Brain Tumor Diagnostics and Therapeutics Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-18Z13201

Global Brain Tumor Diagnostics and Therapeutics Market Research Report 2025

FEATURED COMPANIES

Brain Tumor Diagnostics and Therapeutics Market Size

Brain Tumor Diagnostics and Therapeutics Market

Scope of Brain Tumor Diagnostics and Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Brain Tumor Diagnostics and Therapeutics Market report?

What are the Application segmentation covered in the Brain Tumor Diagnostics and Therapeutics Market report?

What are the Type segmentation covered in the Brain Tumor Diagnostics and Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS